Details for 2021178047

Up to date per 04.04.2026

Actions

Title / Product Name

19-NOR C3,3-DISUBSTITUIERTES C21-N-PYRAZOLYL-STEROID ZUR VERWENDUNG IN DER THERAPIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021178047

EP Publication Number

3909966

E-Number

1811774

Language

PCT Number

Publication Date

17.11.2021 A

09.07.2025 B1

Registration Date

09.07.2025

AT Publication Date

15.07.2025

Application Date

17.04.2014

Registration Number

Priorities

17.04.2013

PCT/CN2013/074323

IPC

C07J 43/00 20060101AFI20250110BHEP

Maximum Duration of Protection

17.04.2034

Owner

Sage Therapeutics, Inc.55 Cambridge Parkway Cambridge, MA 02142US

Representative

No representatives present

Inventor

BOTELLA, Gabriel Martinez Wayland, 01778US

HARRISON, Boyd L. Princeton Junction, 08550US

ROBICHAUD, Albert Jean New Jersey, 08551US

SALITURO, Francesco G. Marlborough, 01752US

BERESIS, Richard Thomas Shanghai, 200040CN

Information about Fees